Korjuny is a medicine used to treat adults with malignant ascites (a build-up of fluid in the abdomen) caused by cancers that are EpCAM-positive (meaning that the cancer cells have a molecule on their surface called epithelial cellular adhesion molecule). Korjuny is used in patients who cannot have any further cancer treatment. Korjuny contains the active substance catumaxomab.
Therapeutic Indication
### Therapeutic indication Korjuny is indicated for the intraperitoneal treatment of malignant ascites in adults with epithelial cellular adhesion molecule (EpCAM)-positive carcinomas, who are not eligible for further systemic anticancer therapy.
Therapeutic Area (MeSH)
ATC Code
L01FX03
ATC Item
catumaxomab
Pharmacotherapeutic Group
Antineoplastic agents
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| catumaxomab | N/A | Catumaxomab |
EMA Name
Korjuny
Medicine Name
Korjuny
Aliases
N/ANo risk management plan link.
